Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2023

Bhattacharya U, Kamran M, Manai M, Cristofanilli M, Ince TA. Cell-of-Origin Targeted Drug Repurposing for Triple-Negative and Inflammatory Breast Carcinoma with HDAC and HSP90 Inhibitors Combined with Niclosamide. Cancers (Basel). 2023;15(2).

Rozental O, Cushing MM, Shander A, Isbister JP, Lasocki S, Meybohm P, et al. Penny-wise and pound-foolish: the challenges of preoperative anaemia management. Br J Anaesth. 2023;131(2):214-221.

Maura F, Ziccheddu B, Xiang JZ, Bhinder B, Rosiene J, Abascal F, et al. Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells. Blood Cancer Discov. 2023;4(3):208-227.

Sarachakov A, Varlamova A, Svelolkin V, Polyakova M, Valencia I, Unkenholz C, et al. Spatial Mapping of Human Hematopoiesis at Single Cell Resolution Reveals Aging-Associated Topographic Remodeling. Blood. 2023.

Assaad MA, Gundem G, Liechty B, Sboner A, Medina J, Papaemmanuil E, et al. The importance of escalating molecular diagnostics in patients with low-grade pediatric brain cancer. Cold Spring Harb Mol Case Stud. 2023;9(4).

Assaad MA, Shin N, Sigouros M, Manohar J, Antysheva Z, Kotlov N, et al. Deciphering the origin and therapeutic targets of cancer of unknown primary: a case report that illustrates the power of integrative whole-exome and transcriptome sequencing analysis. Front Oncol. 2023;13:1274163.

Pederzoli F, Raffo M, Pakula H, Ravera F, Nuzzo PV, Loda M. "Stromal cells in prostate cancer pathobiology: friends or foes?". Br J Cancer. 2023;128(6):930-939.

Pitman MB, Centeno BA, Reid MD, Saeig M, Siddiqui MT, Layfield LJ, et al. A brief review of the WHO reporting system for pancreaticobiliary cytopathology. J Am Soc Cytopathol. 2023;12(4):243-250.

Hissong E, Zhao L, Shi J. Clinicopathologic and Molecular Features of Pancreatic Ductal Adenocarcinomas Harboring Alterations in COMPASS-like Complex Genes. Arch Pathol Lab Med. 2023;147(9):1050-1059.

Adegbite BO, Abramson MH, Gutgarts V, Musteata MF, Chauhan K, Muwonge AN, et al. Dasatinib nephrotoxicity correlates with patient-specific pharmacokinetics. medRxiv. 2023.